Tmc3 Development Corporation

“Section a, line 11 - 990 review process the preparer reviews the form 990 with the cfo. The form 990 is distributed to and reviewed by the audit committee. The final 990 is made available to the board of directors prior to filing. Section b, line 12c - conflict of interest compliance conflict of interest statements are completed annually by the board of directors, officers and key employees. The statements are reviewed by the legal department. If a conflict were to arise, the board member would be required to dismiss himself/herself from any discussions or decisions regarding the area of conflict. Section b, line 15 - compensation approval the tmc board of director's meets annually as part of the president's annual review and compensation. The board reviews the performance of the company and the president's performance to decide compensation. During this process, the board also receives performance review and compensation information on each member of the executive leadership team. Section b, line 19 - public disclosure of governing documents tmc3 development corporation's governing documents, conflict of interest policy and financial statements are available upon request.”

“Form 990, part i, line 1 & part iii, lines 1 & 4a tmc3 development corporation is organized and will operate exclusively to support the texas medical center, a texas nonprofit corporation, by facilitating the development and financing of projects and facilities and performing such other functions as may be necessary or appropriate to fulfill the purposes of tmc3 development corporation. Texas medical center was organized and is operated to facilitate patient care, medical research and medical education in the largest medical complex in the world, the texas medical center located in houston, texas. Among tmc's activities is advancing life sciences by nurturing cross-institutional collaboration, creativity and innovation. A key component of this activity is development of the tmc3 collaborative campus ("tmc3"). In 2014, tmc brought together leaders of its member institutions and the community to create a campus-wide, strategic plan. The goal was to identify key areas for collaboration among member institutions to establish tmc as a center for life sciences. Around the same time, four of the largest member institutions approached tmc about purchasing land for additional laboratory space. From this effort came tmc3, a project that will advance life sciences and accelerate research discoveries to improve human health throughout the world. Tmc3 will unite the brightest minds in life sciences in one place for one purpose-to translate fundamental discoveries into solutions to improve and advance human health. Tmc3 founding institutions (the "founding institutions") are tmc, texas a&m university health science center, the university of texas health science center houston and the university of texas m.d. Anderson cancer center. Tmc3 development corporation was organized and will operate to facilitate tmc's role as lead party in the development and financing of tmc3. Specifically, it will lease from tmc the land on which tmc3 will be located. It will enter into sublease agreements with the founding institutions and other occupants of tmc3, thereby facilitating the development and financing of tmc3.”